Literature DB >> 21343615

Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Motohiko Oshima1, Mitsuhiro Endoh, Takaho A Endo, Tetsuro Toyoda, Yaeko Nakajima-Takagi, Fumihiro Sugiyama, Haruhiko Koseki, Michael Kyba, Atsushi Iwama, Mitsujiro Osawa.   

Abstract

Forced expression of the transcription factor HoxB4 has been shown to enhance the self-renewal capacity of mouse bone marrow hematopoietic stem cells (HSCs) and confer a long-term repopulating capacity to yolk sac and embryonic stem (ES) cell-derived hematopoietic precursors. The fact that ES cell-derived precursors do not repopulate bone marrow without HoxB4 underscores an important role for HoxB4 in the maturation of ES-derived hematopoietic precursors into long-term repopulating HSCs. However, the precise molecular mechanism underlying this process is barely understood. In this study, we performed a genome-wide analysis of HoxB4 using ES cell-derived hematopoietic stem/progenitor cells. The results revealed many of the genes essential for HSC development to be direct targets of HoxB4, such as Runx1, Scl/Tal1, Gata2, and Gfi1. The expression profiling also showed that HoxB4 indirectly affects the expression of several important genes, such as Lmo2, Erg, Meis1, Pbx1, Nov, AhR, and Hemgn. HoxB4 tended to activate the transcription, but the down-regulation of a significant portion of direct targets suggested its function to be context-dependent. These findings indicate that HoxB4 reprograms a set of key regulator genes to facilitate the maturation of developing HSCs into repopulating cells. Our list of HoxB4 targets also provides novel candidate regulators for HSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343615      PMCID: PMC3296623          DOI: 10.1182/blood-2010-12-323212

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.

Authors:  Hui Zeng; Raif Yücel; Christian Kosan; Ludger Klein-Hitpass; Tarik Möröy
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  A functional screen to identify novel effectors of hematopoietic stem cell activity.

Authors:  Eric Deneault; Sonia Cellot; Amélie Faubert; Jean-Philippe Laverdure; Mélanie Fréchette; Jalila Chagraoui; Nadine Mayotte; Martin Sauvageau; Stephen B Ting; Guy Sauvageau
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

3.  A major role of TGF-beta1 in the homing capacities of murine hematopoietic stem cell/progenitors.

Authors:  Claude Capron; Catherine Lacout; Yann Lécluse; Valérie Jalbert; Hédia Chagraoui; Sabine Charrier; Anne Galy; Annelise Bennaceur-Griscelli; Elisabeth Cramer-Bordé; William Vainchenker
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

4.  Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.

Authors:  Anthony E Boitano; Jian Wang; Russell Romeo; Laure C Bouchez; Albert E Parker; Sue E Sutton; John R Walker; Colin A Flaveny; Gary H Perdew; Michael S Denison; Peter G Schultz; Michael P Cooke
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

5.  Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.

Authors:  Jie Jiang; Hui Yu; Yan Shou; Geoffrey Neale; Sheng Zhou; Taihe Lu; Brian P Sorrentino
Journal:  Blood       Date:  2010-04-14       Impact factor: 22.113

6.  HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

Authors:  Michael Kyba; Rita C R Perlingeiro; George Q Daley
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

7.  Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells.

Authors:  Han M Lee; Hui Zhang; Vincent Schulz; David P Tuck; Bernard G Forget
Journal:  Blood       Date:  2010-04-19       Impact factor: 22.113

8.  HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.

Authors:  J Antonchuk; G Sauvageau; R K Humphries
Journal:  Exp Hematol       Date:  2001-09       Impact factor: 3.084

9.  Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation.

Authors:  G Bhardwaj; B Murdoch; D Wu; D P Baker; K P Williams; K Chadwick; L E Ling; F N Karanu; M Bhatia
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

10.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

View more
  26 in total

1.  Identification and characterization of Hoxa9 binding sites in hematopoietic cells.

Authors:  Yongsheng Huang; Kajal Sitwala; Joel Bronstein; Daniel Sanders; Monisha Dandekar; Cailin Collins; Gordon Robertson; James MacDonald; Timothee Cezard; Misha Bilenky; Nina Thiessen; Yongjun Zhao; Thomas Zeng; Martin Hirst; Alfred Hero; Steven Jones; Jay L Hess
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Authors:  Rong Fan; Sabrina Bonde; Peng Gao; Brendan Sotomayor; Changya Chen; Tyler Mouw; Nicholas Zavazava; Kai Tan
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

3.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

4.  Modulating the malignancy of Hox proteins.

Authors:  Michael Kyba
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

5.  HoxBlinc RNA Recruits Set1/MLL Complexes to Activate Hox Gene Expression Patterns and Mesoderm Lineage Development.

Authors:  Changwang Deng; Ying Li; Lei Zhou; Joonseok Cho; Bhavita Patel; Naohiro Terada; Yangqiu Li; Jörg Bungert; Yi Qiu; Suming Huang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

6.  The Hox proteins Ubx and AbdA collaborate with the transcription pausing factor M1BP to regulate gene transcription.

Authors:  Amel Zouaz; Ankush Auradkar; Marie Claire Delfini; Meiggie Macchi; Marine Barthez; Serge Ela Akoa; Leila Bastianelli; Gengqiang Xie; Wu-Min Deng; Stuart S Levine; Yacine Graba; Andrew J Saurin
Journal:  EMBO J       Date:  2017-09-04       Impact factor: 11.598

7.  HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.

Authors:  Céline Auvray; Andrée Delahaye; Françoise Pflumio; Rima Haddad; Sophie Amsellem; Ayda Miri-Nezhad; Loïc Broix; Azzedine Yacia; Frédérique Bulle; Serge Fichelson; Isabelle Vigon
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

8.  A portable platform for stepwise hematopoiesis from human pluripotent stem cells within PET-reinforced collagen sponges.

Authors:  Yoshinori Sugimine; Akira Niwa; Hiroyuki Matsubara; Kazuki Kobayashi; Yasuhiko Tabata; Toshio Heike; Tatsutoshi Nakahata; Megumu K Saito
Journal:  Int J Hematol       Date:  2016-09-06       Impact factor: 2.490

9.  Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in mice.

Authors:  Joanna S Kerley-Hamilton; Heidi W Trask; Christian J A Ridley; Eric Dufour; Corina Lesseur; Carol S Ringelberg; Karen L Moodie; Samantha L Shipman; Murray Korc; Jiang Gui; Nicholas W Shworak; Craig R Tomlinson
Journal:  Toxicol Sci       Date:  2012-01-06       Impact factor: 4.849

10.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.